407 related articles for article (PubMed ID: 29253099)
1. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
[TBL] [Abstract][Full Text] [Related]
3. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology.
Hartnell IJ; Woodhouse D; Jasper W; Mason L; Marwaha P; Graffeuil M; Lau LC; Norman JL; Chatelet DS; Buee L; Nicoll JAR; Blum D; Dorothee G; Boche D
Brain; 2024 Feb; 147(2):590-606. PubMed ID: 37703311
[TBL] [Abstract][Full Text] [Related]
4. Tau Protein and Frontotemporal Dementias.
Goedert M; Spillantini MG; Falcon B; Zhang W; Newell KL; Hasegawa M; Scheres SHW; Ghetti B
Adv Exp Med Biol; 2021; 1281():177-199. PubMed ID: 33433876
[TBL] [Abstract][Full Text] [Related]
5. Heritability in frontotemporal tauopathies.
Forrest SL; Halliday GM; McCann H; McGeachie AB; McGinley CV; Hodges JR; Piguet O; Kwok JB; Spillantini MG; Kril JJ
Alzheimers Dement (Amst); 2019 Dec; 11():115-124. PubMed ID: 30723775
[TBL] [Abstract][Full Text] [Related]
6. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
[TBL] [Abstract][Full Text] [Related]
7. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.
Lladó A; Sánchez-Valle R; Rey MJ; Ezquerra M; Tolosa E; Ferrer I; Molinuevo JL;
J Neurol; 2008 Apr; 255(4):488-94. PubMed ID: 18357425
[TBL] [Abstract][Full Text] [Related]
9. The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies.
Nijholt DA; van Haastert ES; Rozemuller AJ; Scheper W; Hoozemans JJ
J Pathol; 2012 Apr; 226(5):693-702. PubMed ID: 22102449
[TBL] [Abstract][Full Text] [Related]
10. Frontotemporal Dementia Caused by the P301L Mutation in the MAPT Gene: Clinicopathological Features of 13 Cases from the Same Geographical Origin in Barcelona, Spain.
Borrego-Écija S; Morgado J; Palencia-Madrid L; Grau-Rivera O; Reñé R; Hernández I; Almenar C; Balasa M; Antonell A; Molinuevo JL; Lladó A; Martínez de Pancorbo M; Gelpi E; Sánchez-Valle R
Dement Geriatr Cogn Disord; 2017; 44(3-4):213-221. PubMed ID: 28934750
[TBL] [Abstract][Full Text] [Related]
11. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).
Dickson DW; Kouri N; Murray ME; Josephs KA
J Mol Neurosci; 2011 Nov; 45(3):384-9. PubMed ID: 21720721
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation.
Morino H; Kurashige T; Matsuda Y; Ono M; Sahara N; Miyasaka T; Soeda Y; Shimada H; Yamazaki Y; Takahashi T; Izumi Y; Ito H; Maruyama H; Higuchi M; Arihiro K; Suhara T; Takashima A; Kawakami H
Mov Disord Clin Pract; 2024 Jun; 11(6):720-727. PubMed ID: 38605589
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological correlations in behavioural variant frontotemporal dementia.
Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
[TBL] [Abstract][Full Text] [Related]
14. Neuropathology of familial tauopathy.
Tsuboi Y
Neuropathology; 2006 Oct; 26(5):471-4. PubMed ID: 17080727
[TBL] [Abstract][Full Text] [Related]
15. Preferential tau aggregation in von Economo neurons and fork cells in frontotemporal lobar degeneration with specific MAPT variants.
Lin LC; Nana AL; Hepker M; Hwang JL; Gaus SE; Spina S; Cosme CG; Gan L; Grinberg LT; Geschwind DH; Coppola G; Rosen HJ; Miller BL; Seeley WW
Acta Neuropathol Commun; 2019 Oct; 7(1):159. PubMed ID: 31640778
[TBL] [Abstract][Full Text] [Related]
16. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN].
Tsuboi Y
Brain Nerve; 2009 Nov; 61(11):1285-91. PubMed ID: 19938685
[TBL] [Abstract][Full Text] [Related]
17. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study.
Valentino RR; Scotton WJ; Roemer SF; Lashley T; Heckman MG; Shoai M; Martinez-Carrasco A; Tamvaka N; Walton RL; Baker MC; Macpherson HL; Real R; Soto-Beasley AI; Mok K; Revesz T; Christopher EA; DeTure M; Seeley WW; Lee EB; Frosch MP; Molina-Porcel L; Gefen T; Redding-Ochoa J; Ghetti B; Robinson AC; Kobylecki C; Rowe JB; Beach TG; Teich AF; Keith JL; Bodi I; Halliday GM; Gearing M; Arzberger T; Morris CM; White CL; Mechawar N; Boluda S; MacKenzie IR; McLean C; Cykowski MD; Wang SJ; Graff C; Nagra RM; Kovacs GG; Giaccone G; Neumann M; Ang LC; Carvalho A; Morris HR; Rademakers R; Hardy JA; Dickson DW; Rohrer JD; Ross OA;
Lancet Neurol; 2024 May; 23(5):487-499. PubMed ID: 38631765
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies.
de Silva R; Lashley T; Strand C; Shiarli AM; Shi J; Tian J; Bailey KL; Davies P; Bigio EH; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday G; MacKenzie J; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown SM; Holton J; Lees A; Revesz T; Mann DM
Acta Neuropathol; 2006 Apr; 111(4):329-40. PubMed ID: 16552612
[TBL] [Abstract][Full Text] [Related]
19. Invited review: Neuropathology of tauopathies: principles and practice.
Kovacs GG
Neuropathol Appl Neurobiol; 2015 Feb; 41(1):3-23. PubMed ID: 25495175
[TBL] [Abstract][Full Text] [Related]
20. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.
Ogaki K; Li Y; Takanashi M; Ishikawa K; Kobayashi T; Nonaka T; Hasegawa M; Kishi M; Yoshino H; Funayama M; Tsukamoto T; Shioya K; Yokochi M; Imai H; Sasaki R; Kokubo Y; Kuzuhara S; Motoi Y; Tomiyama H; Hattori N
Parkinsonism Relat Disord; 2013 Jan; 19(1):15-20. PubMed ID: 22818528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
